SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as the community speculates on the potential passage of the Clarity Act, with many hoping it will establish the token as a digital commodity and clarify its long-term utility for collateralized payments. While long-term holders debate whether recent price fluctuations represent institutional accumulation or ongoing market manipulation, community sentiment remains sharply divided between those calling for patience in anticipation of institutional adoption and those frustrated by the prolonged downward trend and perceived lack of clear communication from project leadership.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors monitor the commercial launch of YARTEMLEA and weigh upcoming catalysts, including European regulatory milestones and potential milestone payments from the Novo Nordisk partnership. While the community is actively debating the company's valuation and the speed of revenue ramp-up, sentiment remains focused on long-term potential despite recent volatility and discussions around short interest.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

GDX is experiencing extreme volatility as investors react to a sharp pullback in gold prices, driven by profit-taking and margin adjustments following a historic price rally. The community is actively debating whether this decline represents a major trend reversal or a healthy consolidation, with many investors closely watching support levels while speculating on the impact of ongoing geopolitical tensions in the Middle East.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. (ANNA) is surging as retail investors rally around its low-float status and strategic role in the European energy sector, with community discussion heavily focused on a potential short squeeze fueled by massive volume and geopolitical supply chain risks. Traders are actively debating the sustainability of this momentum, contrasting bullish sentiment driven by natural gas supply shortages against concerns over volatility and the potential for rapid retracement.

Cheniere Energy, Inc. engages in liquefied natural gas (LNG) related businesses. It owns and operates LNG terminals, develops, constructs, and operates liquefaction projects near Corpus Christi, Texas, and at the Sabine Pass LNG terminal. The company was founded by Charif Souki in 1996 and is headquartered in Houston, TX.

Cheniere Energy Inc.

Cheniere Energy is attracting significant attention as investors speculate on its potential inclusion in the S&P 500, a move fueled by its strong market position and role in the critical U.S. LNG export sector. Meanwhile, the community is actively debating the stock's growth trajectory and its value proposition compared to emerging competitors like Venture Global, with sentiment heavily influenced by geopolitical energy shifts and robust institutional interest.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending as investors react to a significant stock price drop following a quarterly earnings report that showed revenue missing estimates and a continued full-year loss. The community is heavily divided between bears pointing to the company's high debt levels and poor leadership performance, and bulls who are buying the dip in anticipation of future cost reductions and a long-awaited strategic partnership with POSCO.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp. is trending as investors weigh significant earnings growth and a massive backlog against ongoing concerns regarding production timelines and short-selling volatility. The community remains focused on the company's role as a domestic supplier of critical minerals for the defense sector, with active debate surrounding potential catalysts like upcoming project milestones and institutional positioning.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It operates through the following segments: Uranium, Rare Earth Elements (REE), and Heavy Mineral Sands (HMS). The uranium segment engages in conventional and ISR uranium extraction, recovery and sales of uranium from mineral properties and the recycling of uranium-bearing materials generated by third parties along with the exploration, permitting and evaluation of uranium properties in the U.S. The REE segment is engaged in the company’s initiatives to progress towards full REE separation capabilities at the Mill to produce both light and heavy separated REE oxides in the coming years. The HMS segment engages in the exploration, development and recovery of HMS at the Kwale Project, Bahia Project, Vara Mada Project and the company’s equity method investments in the Donald Project JV and Tate. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels Inc. is drawing significant attention as investors react to the company's strategic positioning within the North American uranium and rare-earth supply chains, further buoyed by a fresh buy rating and price target from Goldman Sachs. Community discourse is currently focused on the company's unique production infrastructure and potential for long-term growth, even as share prices experience short-term volatility tied to broader market trends and conference-related profit taking.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending as the community closely monitors the competitive dynamics following a rival's recent FDA approval and anticipates significant clinical data presentations at the upcoming ASH meeting. Investors are heavily focused on potential buyout interest from Incyte, emphasizing the stock's perceived undervaluation and strong pipeline synergy as key drivers for long-term growth.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is currently trending as investors debate the stock's valuation and technical support levels amid intense market volatility surrounding potential tariff impacts on the semiconductor sector. The community is actively discussing the stock's long-term growth prospects in AI and data centers versus its near-term price pressure, with many focusing on whether current levels represent a deep-value buying opportunity or a signal for further downside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Halper Sadeh LLC Encourages Inotiv, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Inotiv, Inc. (NASDAQ: NOTV) breached their fiduciary duties to shareholders. If you currently...

Inotiv, Inc. (NOTV) Reports Q3 Loss, Tops Revenue Estimates

Inotiv (NOTV) delivered earnings and revenue surprises of +20.00% and +4.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Esperion Therapeutics (ESPR) Reports Q2 Loss, Tops Revenue Estimates

Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of +88.24% and +24.28%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Inotiv, Inc. (NOTV) Reports Q2 Loss, Tops Revenue Estimates

Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. It operates under the Discovery and Safety Assessment (DSA) and Research Models and Services (RMS) segments. The DSA segment focuses on drug discovery and development services. The RMS segment includes commercial production and selling research models, diets, bedding, and bioproducts. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.

NOTV
Inotiv Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NOTV News

NOTVInotiv Inc